FDA Investigator Philip J Boston
Philip J Boston has conducted inspections on 73 sites in 1 countries as of 29 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
73
Last Inspection Date:
29 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Philip J Boston:
Adree N Anderson,
Alan M Roberts,
Anthony R Bucks,
Audrey N Vigil,
Bonnie E Pierson,
Brett R Havranek,
Brian J Davis,
Carl A Huffman, III,
CDR Sean T Creighton,
Ceisha C Ukatu,
Chase S Baldwin,
Christi L Bellmore,
Christina L Bigham,
Clifford F Long,
Conner N Mann,
Dana D Carter, SR DDS,
Danial S Hutchison,
Darrah,
David K Glasgow,
Dawn C Olenjack,
Dennis R Butcher,
Dewayne E Whitlock,
Donna K Speer,
Dustin K Hampton,
Dylan C Grippi,
Edward E Lockwood (EEL),
Elizabeth L Holmes,
Eric C Fox,
Eric C Nielsen,
Eric M Padgett,
Erickson,
Erika V Butler,
Fred K Kelly,
Freed A Sharif,
Georgia A Layloff,
Gwyn G Dickinson,
Hassan Ali,
James D Planchon,
James I Giefer,
James L Finn,
Janete A Oliveira,
Janice A Hawkins,
Jason H Wieners,
Jeffery L Sumter,
Jessica L Peterson,
Jill J Tillman,
John A Iwen,
Joseph D Gong,
Joseph R Haynes,
Justin R Hays,
Karen C Daugherty,
Karen M Montgomery (KMM),
Kathleen B Swat,
Kellia N Hicks,
Kelly D Sheppard,
Kristi B Panzer,
LCDR Matthew J Morrison,
Lisa L Flores,
Lori S Lawless,
Maksim A Levenchuk,
Mark G Peterson,
Martina E Lagrange,
Mary A Millner,
Mary K Concannon,
Mary L Schuckmann,
Matthew H Hunt,
Matthew M Schuckmann,
Meisha R Sampson,
Michele Perry Williams,
Michelle J Glembin,
Misty D Harvey,
Monica E Murie,
Pablo Alcantara,
Pamela L Velez Vega,
Patricia A Brown,
Peng Zhou,
Rebeca Ulloa,
Robert D Tollefsen,
Robert J Ham,
Robert J Nesselhauf,
Samuel K Gibbons, Jr,
Shafiq S Ahadi,
Shana L Williams,
Shanna R Haden,
Sheri L Stephenson,
Sherry G Bous,
Shirley J Berryman,
Steven D Kehoe,
Sullan,
Tara L Greene,
Thai T Duong,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Wayne W Grundstrom,
William C Corley
Philip J Boston's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more